109 related articles for article (PubMed ID: 23673903)
1. Monascin improves diabetes and dyslipidemia by regulating PPARγ and inhibiting lipogenesis in fructose-rich diet-induced C57BL/6 mice.
Lee BH; Hsu WH; Huang T; Chang YY; Hsu YW; Pan TM
Food Funct; 2013 Jun; 4(6):950-9. PubMed ID: 23673903
[TBL] [Abstract][Full Text] [Related]
2. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
3. Monascus-fermented yellow pigments monascin and ankaflavin showed antiobesity effect via the suppression of differentiation and lipogenesis in obese rats fed a high-fat diet.
Lee CL; Wen JY; Hsu YW; Pan TM
J Agric Food Chem; 2013 Feb; 61(7):1493-500. PubMed ID: 23360447
[TBL] [Abstract][Full Text] [Related]
4. Monascus-fermented red mold dioscorea protects mice against alcohol-induced liver injury, whereas its metabolites ankaflavin and monascin regulate ethanol-induced peroxisome proliferator-activated receptor-γ and sterol regulatory element-binding transcription factor-1 expression in HepG2 cells.
Cheng CF; Pan TM
J Sci Food Agric; 2018 Mar; 98(5):1889-1898. PubMed ID: 28902410
[TBL] [Abstract][Full Text] [Related]
5. Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat.
Prakash P; Singh V; Jain M; Rana M; Khanna V; Barthwal MK; Dikshit M
Eur J Pharmacol; 2014 Mar; 727():15-28. PubMed ID: 24486395
[TBL] [Abstract][Full Text] [Related]
6. The Monascus metabolite monascin against TNF-α-induced insulin resistance via suppressing PPAR-γ phosphorylation in C2C12 myotubes.
Lee BH; Hsu WH; Liao TH; Pan TM
Food Chem Toxicol; 2011 Oct; 49(10):2609-17. PubMed ID: 21777645
[TBL] [Abstract][Full Text] [Related]
7. A novel PPARgamma agonist monascin's potential application in diabetes prevention.
Hsu WH; Pan TM
Food Funct; 2014 Jul; 5(7):1334-40. PubMed ID: 24752777
[TBL] [Abstract][Full Text] [Related]
8. A novel natural Nrf2 activator with PPARγ-agonist (monascin) attenuates the toxicity of methylglyoxal and hyperglycemia.
Hsu WH; Lee BH; Chang YY; Hsu YW; Pan TM
Toxicol Appl Pharmacol; 2013 Nov; 272(3):842-51. PubMed ID: 23954466
[TBL] [Abstract][Full Text] [Related]
9. Monacolin K and monascin attenuated pancreas impairment and hyperglycemia induced by advanced glycation endproducts in BALB/c mice.
Hsu WH; Lu SS; Lee BH; Hsu YW; Pan TM
Food Funct; 2013 Dec; 4(12):1742-50. PubMed ID: 24154804
[TBL] [Abstract][Full Text] [Related]
10. Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway.
Xia M; Liu Y; Guo H; Wang D; Wang Y; Ling W
Hepatology; 2013 Aug; 58(2):564-75. PubMed ID: 23300015
[TBL] [Abstract][Full Text] [Related]
11. Consumption of soy protein isolate reduces hepatic SREBP-1c and lipogenic gene expression in wild-type mice, but not in FXR-deficient mice.
Hashidume T; Sasaki T; Inoue J; Sato R
Biosci Biotechnol Biochem; 2011; 75(9):1702-7. PubMed ID: 21897047
[TBL] [Abstract][Full Text] [Related]
12. Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-γ and SREBP-1c in diet-induced obese mice.
Villalpando-Arteaga EV; Mendieta-Condado E; Esquivel-Solís H; Canales-Aguirre AA; Gálvez-Gastélum FJ; Mateos-Díaz JC; Rodríguez-González JA; Márquez-Aguirre AL
Food Funct; 2013 Apr; 4(4):618-26. PubMed ID: 23389749
[TBL] [Abstract][Full Text] [Related]
13. Symplocos cochinchinensis enhances insulin sensitivity via the down regulation of lipogenesis and insulin resistance in high energy diet rat model.
Antu KA; Riya MP; Nair A; Mishra A; Srivastava AK; Raghu KG
J Ethnopharmacol; 2016 Dec; 193():500-509. PubMed ID: 27686268
[TBL] [Abstract][Full Text] [Related]
14. Regulation of hepatic PPARgamma2 and lipogenic gene expression by melanocortin.
Poritsanos NJ; Wong D; Vrontakis ME; Mizuno TM
Biochem Biophys Res Commun; 2008 Nov; 376(2):384-8. PubMed ID: 18789887
[TBL] [Abstract][Full Text] [Related]
15. Lipoic acid prevents liver metabolic changes induced by administration of a fructose-rich diet.
Castro MC; Massa ML; Schinella G; Gagliardino JJ; Francini F
Biochim Biophys Acta; 2013 Jan; 1830(1):2226-32. PubMed ID: 23085069
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Th2 cytokine production in T cells by monascin via PPAR-γ activation.
Hsu WH; Lee BH; Hsu YW; Pan TM
J Agric Food Chem; 2013 Aug; 61(34):8126-33. PubMed ID: 23848565
[TBL] [Abstract][Full Text] [Related]
17. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis.
Rhee SD; Kim CH; Park JS; Jung WH; Park SB; Kim HY; Bae GH; Kim TJ; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):9-18. PubMed ID: 22742899
[TBL] [Abstract][Full Text] [Related]
18. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
19. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.
Zhang YL; Hernandez-Ono A; Siri P; Weisberg S; Conlon D; Graham MJ; Crooke RM; Huang LS; Ginsberg HN
J Biol Chem; 2006 Dec; 281(49):37603-15. PubMed ID: 16971390
[TBL] [Abstract][Full Text] [Related]
20. Fructose induced lipogenesis: from sugar to fat to insulin resistance.
Samuel VT
Trends Endocrinol Metab; 2011 Feb; 22(2):60-5. PubMed ID: 21067942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
